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SUMMARY OF RECOMMENDATIONS
 
I. MONITORING 
• Actively monitor national HIV quality metrics within 
health plans and health care systems. 
• Adopt new metrics to identify and intervene with 
patients at risk for disengaging from care. 
• Build quality improvement systems that include 
persons “not in care.” 
II. INTERVENING 
• Adopt systems improvements to normalize  
and routinize HIV screening. 
• Maximize the capacity of electronic medical 
records to adopt provider- and system-level 
interventions to streamline and routinize 
HIV screening in accordance with CDC 
recommendations. 
• Utilize EMR algorithms to identify patients in need 
of HIV testing or who have fallen out of care. 
• Enhance capacity to identify cases of acute 
infection through best available testing technologies 
and timely clinical interventions. 
• Expand active referral programs for linkage to care. 
• Expand low cost evidence-informed approaches  
to promote retention in care. 
• Establish programs to actively re-engage people in 
care who have experienced treatment interruptions. 
• Address financial barriers to HIV care and 
treatment. 
III.  CHANGING POLICY (through 
collaboration with federal, state,  
and local policy makers) 
• Establish “Data to Care” programs in all state 
health departments. 
• Clarify responsibilities and strengthen coordination 
among federal, state, and local agencies. 
• Further integrate grantee funding and oversight 
between CDC and HRSA. 
• Establish standards for Medicare, Medicaid, and 
marketplaces to monitor core HIV indicators, build 
systems to support engagement in HIV care, and 
require fidelity to HHS ART guidelines. 
• Establish state and local data and continuous 
quality improvement collaboratives. 
INTRODUCTION 
The United States is poised to dramatically reduce the scope of its 
HIV epidemic, but this demands increased leadership and attention 
from health plans and health care purchasers (including Medicaid, 
Medicare, marketplaces, and other private purchasers). While health 
plans and purchasers may perceive that HIV-specific prevention 
and care programs are better situated to lead the response to the 
epidemic, there are a relatively small number of actionable and 
meaningful steps that these entities can take that will improve health 
outcomes, reduce preventable HIV-related health spending, and  
contribute to the development of more tightly integrated systems  
of care. Most importantly, however, from a health plan or purchasing 
perspective, HIV is a chronic condition that can be effectively 
managed. While some individuals with HIV may have extensive and 
complex needs, many are virally suppressed and require limited 
monitoring and laboratory services in addition to their antiretroviral 
therapy (ART) regimens. Effective management can help to make 
them a more predictable-cost population and allow plans and 
purchasers to appropriately tailor services to only those persons  
who need them. 
This report identifies changes in policy and practice in clinics, 
communities, and health care programs to reduce unnecessary 
health spending, increase the effectiveness of services, and increase 
the integration of services. Done right, the same steps that lead to 
appropriate management of care by health plans and purchasers  
also will help to achieve national public health goals. 
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indicate that almost half of all people diagnosed with HIV in the U.S. are 
not receiving regular HIV care, and they account for roughly seven in 
ten HIV transmissions. 
Now is a unique moment when much progress is possible. While some 
diagnosed individuals not in care are uninsured, others have insurance, 
yet are not receiving regular HIV care either because they are not 
engaged in care or because the care they receive is not addressing 
their HIV infection. Therefore, if health plans are able to ensure that all 
of their members with HIV are receiving appropriate HIV medical care, 
then we can dramatically reduce HIV morbidity and mortality, as well as 
onward HIV transmission. New scientific knowledge has created greater 
urgency for finding people soon after diagnosis and starting ART right 
away. In 2015, the START Study, a randomized controlled trial (RCT), 
conclusively demonstrated the clinical benefits for people with HIV 
The HIV care continuum (Figure 1) is used to estimate how many 
people with HIV are engaged in the various stages of care, from 
diagnosis to viral suppression.1 These estimates have received 
considerable attention as a way to measure national, state, and local 
success in supporting all people with HIV to learn their status and 
benefit from effective treatment. The U.S. health system does a fairly 
good job of serving many people living with HIV once they establish an 
ongoing relationship with a qualified HIV care provider.1 The problem is 
that too many are not continually engaged in HIV care, which drives the 
continued cycle of HIV transmission that results in roughly 50,000 new 
infections annually.2 
The Centers for Disease Control and Prevention (CDC) estimates that 
only 8% of HIV transmissions in the U.S. result from persons receiving 
ongoing HIV care (Figure 2). Most surprising, perhaps, CDC data 
Share of all people with HIV at this stage
Diagnosed In Care In Care, Not
Suppressed
In Care, Virally
Suppressed
87%
39%
48%
9%
30%
Requires active re-engagement: Significant 
churning with persons going in and out 
of care and starting and stopping ART
48% of 
all people 
with HIV 
are 
diagnosed 
and not 
in care 
FIGURE 1
Engagement in Care Along the HIV Care Continuum  
(United States and Puerto Rico, 2012)
Source: Frieden TR, Foti KE, Mermin J. Applying public health principles to the HIV epidemic — How are we doing? N Engl J Med. 2015;373(23):2281–2287; Skarbinski J, 
Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588-596.
Note: “In care” means receiving at least two HIV specialty care visits per year at least 90 days apart.
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I.  BETTER MONITORING OF 
ENGAGEMENT IN HIV CARE 
To improve outcomes and reduce costly medical interventions, it is 
necessary to strengthen the systematic monitoring of engagement in 
care and viral suppression. This demands new partnerships and data 
sharing arrangements between health plans, health departments, 
clinical and non-clinical providers, pharmacies, and commercial 
laboratories. The establishment of these arrangements at the local level 
requires new alignment, flexibility, and coordination between various 
federal and state agencies that fund programs and services with 
overlapping goals, working alongside health plans and purchasers. 
Significant work has taken place on this front in recent years. The 
Ryan White HIV/AIDS Program, which is the largest domestic program 
focused solely on the care and treatment of people with HIV, is the 
linchpin of the HIV care system in the U.S. It funds HIV services for 
uninsured and underinsured people with HIV and invests in health care 
capacity and infrastructure to support a nationwide system of HIV care. 
The Health Resources and 
Services Administration 
(HRSA) that administers 
the program estimates 
that in 2014, three-fourths 
of Ryan White clients had 
some form of insurance 
coverage.8 In such cases, 
the program covers needed 
services not covered by 
insurance and assists with 
cost sharing to prevent cost 
from being a barrier to care. 
The program has spent 
several years implementing 
a client-level data system 
that is now operational and 
is yielding new information 
to help policy makers, 
clinics, and other service 
providers take strategic actions to improve the allocation of resources 
and strengthen the quality of care.9 In 2010, the White House 
commissioned the Institute of Medicine (IOM) to examine questions 
related to the monitoring of HIV care in the U.S. The IOM produced two 
reports that identified a core set of HIV clinical care indicators10 and 
provided recommendations for using existing HIV and other data sets 
to strengthen the monitoring of HIV care.11 Concurrently, the Office of 
to begin ART as soon as possible after diagnosis.3,4 In addition, the 
HPTN-052 study, published in 2011, provides strong evidence of the 
effectiveness of early ART in reducing onward HIV transmission.5 This 
RCT found that early treatment reduced the risk of transmission by up 
to 96%. A third RCT, the SMART Study, published in 2006, tested a 
strategy of interrupted ART and found a 160% increased risk of death 
in persons not receiving continuous ART.6,7 The challenge for the health 
system is not only to get persons diagnosed and to start ART, but also 
to achieve and maintain high levels of adherence to care and treatment. 
For a variety of reasons, a sizable share of people with HIV have started 
care, even may have started ART, but subsequently disengage from 
care. New approaches are needed to systematically identify and engage 
these individuals. 
Expanded health insurance coverage resulting from the Affordable 
Care Act (ACA) and changes in how health care is delivered create 
new opportunities for progress. Some ACA marketplace plans have 
adopted formulary policies that place all ART medications on the 
highest cost tiers. Such practices are inconsistent with federal ART 
treatment guidelines and appear discriminatory against people with 
HIV. These policies and practices must be ended. On the whole, 
however, Medicaid, Medicare, private group health plans, and 
most ACA marketplace plans provide reasonable prescription drug 
coverage for people with HIV. Therefore, insurance already covers 
what is overwhelmingly the most costly component of HIV care, 
suggesting that it is not necessary to dramatically expand the scope 
of services provided. Rather, understanding the barriers to care and 
the unique challenges facing some people living with HIV may call for 
expanded approaches to care management and service coordination 
and greater funding for ancillary services for some individuals that 
address adherence to treatment, mental health, substance use, and 
other co-morbid conditions. Notably, the National HIV/AIDS Strategy 
for the United States, updated by the Obama Administration in 2015 
to guide the nation’s efforts through 2020, has prioritized efforts to 
increase knowledge of HIV status, increase engagement in care and 
viral suppression, and expand access to pre-exposure prophylaxis 
(PrEP). Clearly, health plans and purchasers are critical to the 
Strategy’s success. 
There are three primary domains within which health plans and  
health care purchasers can consider taking action: 
1. Better monitoring of engagement in HIV care; 
2. Intervening to support continuous and sustained engagement  
in care and HIV viral suppression; and, 
3. Supporting policy changes at all levels of government to strengthen 
engagement in HIV care. 
Because public health 
surveillance centralizes 
HIV-positive test results 
from all testing service 
providers, and viral load 
and CD4 counts from 
all laboratories and 
medical providers, these 
surveillance systems 
expand information 
beyond what individual 
health plans could 
previously use. 
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HIV/AIDS and Infectious Diseases Policy (OHAIDP) at the Department 
of Health and Human Services (HHS) convened relevant HHS agencies 
along with the Housing Opportunities for People with AIDS (HOPWA) 
program at the Department of Housing and Urban Development (HUD) 
to align definitions for and streamline the reporting of key indicators in 
order to reduce the reporting burden on federal grantees (Figure 3). 
Additionally, the 2015 Updated National HIV/AIDS Strategy revised 
national targets for the next five years.12 While these indicators provide 
a critical barometer of our overall performance as a nation, other 
readily available and evidence-informed measures, indicators, and 
interventions must be pursued in clinical settings to increase rates of 
Undiagnosed Diagnosed,
Not in Care
In Care, Not
Suppressed
Virally
Suppressed
13%
23%
48%
69%
9%
5%
30%
3%
Share of all people with HIV at this stage 
Share of all HIV transmissions at this stage 
The majority of HIV transmissions could be prevented 
by getting all diagnosed persons into HIV care; many of these 
individuals already have health insurance coverage
HIV viral suppression and other clinical outcomes. Attention is also 
needed to address the differential performance of and outcomes in 
specific populations, which may call for more tailored approaches to 
better support certain groups such as adolescents, women, and young 
gay and bisexual men of color. 
One of the more exciting developments in recent years has been the 
expansion of public health surveillance data systems in most states to 
include mandatory reporting of all HIV viral load (measure of HIV virus 
circulating in the body) and CD4 counts (measure of a specific immune 
system component).13 Using evidence of a recent HIV viral load and/
or CD4 count laboratory test as a proxy for HIV medical care visits, 
FIGURE 2
Estimated HIV Transmissions Along the HIV Care Continuum  
(United States and Puerto Rico, 2012)
Source: Frieden TR, Foti KE, Mermin J. Applying public health principles to the HIV epidemic — How are we doing? N Engl J Med. 2015;373(23):2281–2287; Skarbinski J, 
Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588-596.
Note: “In care” means receiving at least two HIV specialty care visits per year at least 90 days apart.
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ACTION STEPS TO BETTER  
MONITOR ENGAGEMENT IN  
HIV MEDICAL CARE 
• Actively monitor HIV quality metrics within health 
plans and health care systems. 
The ability of the health system to expand its capacity to measure 
population-level outcomes depends on the quality of client-level data. 
National indicators, however, are also critically important for improving 
clinical outcomes at the individual level. Therefore, health plans and 
clinics must ensure that they are monitoring priority HIV indicators 
a new public health surveillance tool is available to comprehensively 
monitor engagement along each step on the continuum.14 Expanded 
“active” surveillance has the potential to become a game changer for 
health plans to improve the management of their members with HIV. By 
matching public health surveillance data with health plan data, plans 
are able to narrow the roster of people with HIV not engaged in care 
by excluding those persons seen elsewhere, who have moved, or who 
may have died, thereby facilitating more targeted interventions for those 
persons needing re-engagement services. The CDC’s Data to Care 
Initiative provides resources for health departments, health plans, and 
providers to build systems to adopt “active” surveillance programs to 
improve patient care.15 
Measure Numerator Denominator
HIV positivity Number of HIV positive tests in the 12-month 
measurement period
Number of HIV tests conducted in the 12-month 
measurement period
Late HIV diagnosis Number of persons with a diagnosis of Stage 3 HIV 
infection (AIDS) within 3 months of diagnosis of HIV 
infection in the 12-month measurement period
Number of persons with an HIV diagnosis in  
the 12-month measurement period
Linkage to HIV 
Medical Care
Number of persons who attended a routine HIV 
medical care visit within 3 months of HIV diagnosis
Number of persons with an HIV diagnosis in 
12-month measurement period
Retention in HIV 
Medical Care
Number of persons with an HIV diagnosis who had 
at least one HIV medical care visit in each 6-month 
period of the 24-month measurement period, with  
a minimum of 60 days between the first medical  
visit in the prior 6-month period and the last  
medical visit in the subsequent 6-month period
Number of persons with an HIV diagnosis with  
at least one HIV medical care visit in the first 
6 months of the 24-month measurement period
Antiretroviral 
Therapy (ART) 
Among Persons in 
HIV Medical Care
Number of persons with an HIV diagnosis who are 
prescribed ART in the 12-month measurement period
Number of persons with an HIV diagnosis and  
who had at least one HIV medical care visit in  
the 12-month measurement period
Viral Load 
Suppression Among 
Persons in HIV 
Medical Care
Number of persons with an HIV diagnosis with  
a viral load <200 copies/mL at last test in the 
12-month measurement period
Number of persons with an HIV diagnosis and  
who had at least one HIV medical care visit in  
the 12-month measurement period
Housing Status Number of persons with an HIV diagnosis who 
were homeless or unstably housed in the 12-month 
measurement period
Number of persons with an HIV diagnosis receiving 
HIV services in the last 12 months
Source: Common Indicators for HHS-funded HIV Programs and Services. July 2012. http://hab.hrsa.gov/data/servicesdelivered/2014RWHAPDataReport.pdf. Accessed April 4, 2016. 
FIGURE 3
Common Federal Indicators for HIV Programs and Services
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teams that focus on connecting newly diagnosed members to sites 
within their provider network that are able to deliver HIV-informed 
primary care and connect with other community resources to support 
adherence and impact viral suppression. Depending on the specific 
health plan model, in many circumstances, the most effective approach 
would not be to build new capacity within plans to perform all of these 
functions, but to formalize relationships with existing community 
services providers. Among the specific supports that these UM/CC 
teams can assist with are personal appointment reminders, facilitating 
escorts (if necessary) and increasing consumers’ ability to navigate 
healthcare and related social services. At a minimum, health plans 
must be able to connect members with HIV to primary care within their 
provider networks that is equipped to provide quality HIV care. 
II.  INTERVENING TO SUPPORT 
CONTINUOUS ENGAGEMENT 
IN CARE 
Living with HIV, accessing care in a complex health care system, and 
adhering to ART over one’s life are challenging even for the most 
motivated individuals. Major life challenges, transitions, and stressors 
such as unemployment, relationship distress, family responsibilities, 
and financial distress create immediate, high-priority needs that can 
compete with engaging in HIV care.22 Individuals can cycle and churn 
in and out of care at a single clinic; some estimates suggest that about 
25% of patients churn in 12-month cycles,23 and as many as 60% of 
patients who experience gaps in HIV care will return to care within a 
five- to seven-year timeframe.24 Churning between clinics and regions 
also has been identified through the Market Scan Medicaid Multisite 
Database and other “Big Data” systems, but these aggregated data 
sets may inappropriately classify over a quarter of patients who appear 
to have gaps in care in single source or single state registries, but 
are actually receiving care elsewhere.25 Considerable attention to 
reducing churn due to changes in coverage eligibility (coverage churn) 
is emerging in the era of substantial changes in national plans and 
marketplaces.26,27 
The federal government, working with state and local governments, 
is taking important steps to improve engagement in care along the 
HIV care continuum. In 2013, President Obama issued an Executive 
Order that established an HIV Care Continuum Initiative to focus 
cross-agency attention on high priority areas of collaboration.28 As 
the ACA has increased insurance coverage for people living with HIV, 
there is a new opportunity for the Centers for Medicare and Medicaid 
Services (CMS), Medicare, Medicaid programs, health plans, and 
such as those approved by the National Quality Forum16 and, when 
appropriate for clinical settings, those used by the National HIV/
AIDS Strategy. Clinical management systems can use indicators such 
as time from diagnosis to start of ART and CD4 levels at diagnosis 
(suggesting potential delays in early HIV diagnosis and/or treatment) 
to monitor successes and gaps in quality care.17,18 Given the estimated 
cost savings of averting a single HIV infection ($229,800),19 total cost 
savings from reduced odds of onward infection through quality HIV care 
is compelling. Further, these estimates do not account for the potential 
cost savings attributable to proper management, which prevents 
the development of co-morbid conditions and reduces the need for 
clinical care and services. Purchasers should include new monitoring 
requirements in purchasing specifications and increase payments 
to health plans to account for the added costs associated with more 
extensive monitoring of members with HIV. 
• Adopt new metrics to identify and intervene with 
patients disengaging from care. 
While national indicators focus on important outcomes along the 
continuum of care, other data can be helpful in identifying early signs 
of disengagement from HIV care. For example, missed medical visits 
have been consistently linked to adverse HIV biomarkers and clinical 
outcomes and are measureable and actionable in real time at the clinic 
level.20 Health plans and clinics are in a unique position to access 
outcomes data, as well as visit no-shows, elapsed days out of care, 
and change in clinical outcomes at the individual level. Such data 
can be used proactively to avert extended disengagement from care. 
Monitoring beyond existing national quality indicators should include 
missed clinic visits, as they are a harbinger of patients about to become 
lost to care. Monitoring also may be expanded to include other factors 
identified in local data sets as predictive of outcomes. Models for 
clinical care sites to use their internal data to monitor and intervene in 
a timely fashion with at-risk patients on their panels are emerging,21 
but lack systematic nationwide adoption. Health plans, purchasers, and 
clinics all can contribute to the development of scalable approaches to 
tracking missed clinic visits that lead to wide-scale adoption. 
• Build quality improvement systems that include 
persons “not in care.” 
Health plans, Medicaid programs, and other payers should build 
more comprehensive quality improvement programs that include 
monitoring not only of persons “in care,” but all health plan members 
or beneficiaries with HIV. For instance, health plans could develop 
actionable strategies for managing their members with HIV that support 
continued engagement and, when needed, provide for specific steps 
for re-engaging persons in care. This could be operationalized by 
establishing Utilization Management (UM) or Care Coordination (CC) 
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• Maximize the capacity of electronic medical records 
to adopt provider- and system-level interventions to 
streamline and routinize HIV screening in accordance 
with CDC recommendations. 
Clinical leaders should conduct baseline assessments to identify the 
number and percentage of individuals age 15–65 that have “ever” 
tested for HIV, as well as those that receive an annual HIV test, and 
under what conditions they are tested (e.g., in concert with STD 
screening or diagnosis, as part of preventative care visits, or on patient 
request). They should use this information to determine continuous 
quality improvement activities to steadily increase the number of health 
plan members being tested. Health plans could establish a health 
maintenance goal and provide incentives for certain groups to complete 
an annual HIV test. With certain subpopulations such as gay and 
bisexual men, routine HIV testing, at least annually and perhaps more 
frequently, should become part of the standard of care. 
• Utilize EMR algorithms to identify patients in need  
of HIV testing or who have fallen out of care. 
Purchasers, electronic medical record (EMR) vendors, health plans, 
and clinics should examine systems-level improvements, including the 
development of EMR algorithms to make the offering of an HIV test 
something that happens by default at every patient encounter. In busy 
clinic settings where the sheer number of guidelines and requirements 
quickly reach unmanageable levels, strategies to implement and 
monitor HIV guidelines are needed. This can include providing a check 
box or using automated systems within electronic health records so 
that an HIV test is ordered by default, with the option of the patient 
opting out. Other options include batch test ordering; batch reminder 
cards to patients; “best practice alerts/prompts” with one-click ordering 
for patients at risk and with no evidence of recent HIV testing in the 
electronic health record; linking HIV testing to many panels, including 
STI or Hepatitis C testing, PAP smears, and cholesterol level testing; or 
including HIV testing as part of a health maintenance annual checklist 
in the electronic health record. 
• Enhance the capacity to identify cases of acute 
infection through best available testing technologies 
and timely clinical interventions. 
Until recently, readily available testing technology in the U.S. was 
unable to diagnose infection while persons were in the acute phase, 
when they are most infectious. CDC guidance issued in 2014 
recommends the adoption of fourth-generation HIV testing technologies 
within hospitals and health systems, making it the standard of care 
for HIV testing and screening programs.30 Health plans, hospitals, and 
clinics all have a role to play in increasing access to fourth-generation 
testing, which allows for identification of acute and early infections 
marketplaces, working in conjunction with the Ryan White HIV/AIDS 
Program and health departments, to play a more proactive role in 
developing new models of care that support continual engagement 
and retention in HIV care, informed by integrated data systems to 
allow for more accurate individual-level monitoring and delineation  
of “in care” or “out of care” status. 
ACTION STEPS TO SUPPORT  
CONTINUOUS ENGAGEMENT  
IN HIV CARE 
• Adopt systems improvements to increase the 
percentage of people screened for HIV.
Routine HIV screening programs in clinical settings can ensure that 
all people are offered screening for HIV when they come in for care, 
even without an identified risk factor for HIV infection. Research has 
found that even when risk factors are present, providers do not always 
initiate testing, but routinization is intended to reach persons that would 
not otherwise be identified for testing.29 Routinizing HIV screening 
removes the burden from the individual to self-identify as at risk for 
HIV and thereby reduces potential stigma. In addition, both providers 
and patients sometimes fail to accurately assess risk. Purchasers 
need to establish indicators and link reimbursement to increasing the 
percentage of health plan members or clinic patients who accessed 
health care services within the past year who were screened for HIV. 
Purchasers also should consider “bill above” policies that reimburse for 
screening in settings where capitated or bundled reimbursements could 
otherwise discourage screening. 
As the Affordable Care Act (ACA) has expanded 
access to insurance coverage and as the concept 
of treatment as prevention is integrated into our 
thinking about how we reduce HIV transmission, 
it is important to note that the early stages of the 
continuum traditionally have been the purview of 
health departments and the public health system, 
while the health insurance system and Medicaid 
programs have not seen it as their primary role to 
improve diagnosis, linkage, and retention in care. 
This must change.
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with provider- and clinic-level feedback loops is to forewarn service 
providers when clinical indicators of potential problems arise. Missed 
visits, failure to refill medications, a lapse of more than 90 days after a 
missed visit, or other locally identified indicators can alert providers of 
the need for immediate action. For persons who have stopped engaging 
in care, standard practice must be to take staged and increasingly 
intensive steps to re-engage them and offer tailored options for 
overcoming barriers to continued engagement, similar to differentiated 
care strategies recommended by the World Health Organization.38 
Strategies for re-engaging or averting disengagement are best when 
tailored to one’s specific community, as regions differ in patterns of HIV 
care retention,39 which may reflect important diversities in challenges 
and resources. Community-based participatory practices are critical to 
determining synergies between health plans, health departments, and 
community and institutional providers. Working collaboratively, health 
plans and clinics should establish partnerships with community-based 
organizations to improve the effectiveness of their efforts to retain their 
members in care. These organizations often have unparalleled levels 
of community trust and can offer a range of services, including peer 
support, educational programs, social case management, and other 
services that support adherence to care and ART therapy that may be 
more difficult for health plans to deliver in a typical clinical environment. 
• Address financial barriers to HIV care and treatment. 
The maintenance of health for people with HIV demands lifelong 
engagement in care, although advances in pharmacology have 
dramatically decreased the daily burden of HIV-treatment regimens. 
Nonetheless, like other chronic conditions, consistent presentation 
in care for monitoring, daily medication taking, and frequent 
pharmacy refills are needed. Unlike many other chronic conditions, 
however, the consequences of days without dosing (i.e., over two 
days with no dosing) can be severe for the individual in terms of viral 
rebound,40 thus also creating opportunities for onward transmission. 
Continuity of coverage for medications and for attending regular 
HIV-care visits is critical, and, as noted previously, failures result 
in coverage churn. For those with a choice of health plans, even 
the optimal health plan may impose financial burdens that create 
substantial barriers to care and treatment. This can be the case even 
in programs such as Medicaid, which have reduced cost sharing 
for low-income individuals. With an estimated 40% of people living 
with HIV residing in states that have not yet expanded Medicaid,41 
strategies are needed to support enrollment in marketplace health 
plans and to educate consumers about how to access services and 
how deductibles and other components of enrollee cost-sharing work. 
Furthermore, it is essential to ensure that systems are in place to 
support individuals in order to prevent disengagement in care.42 
that would have been missed with older tests. In addition to purchasing 
this technology, these entities should work collaboratively with health 
departments and community partners to invest in outreach programs 
that link acutely infected individuals to care as soon as possible to 
interrupt transmission within their sexual and social networks. 
• Expand active referral programs for ‘immediate’ 
linkage to care. 
Ensuring seamless and immediate linkage (i.e., within hours or one 
to two days) to medical care at the point of diagnosis is a weak spot 
on the care continuum. Whether conducted by a masters level case 
manager, as was done for the CDC ARTAS study,31,32 or by linkage 
coordinators,33 having a designated person assigned to assist someone 
newly diagnosed with HIV enter medical care has proven to be an 
effective strategy. Efforts should be made to expand such programs, 
tailored to local contexts and resources, to ensure dedicated programs 
and appropriate personnel are in place in every jurisdiction. Health 
plans, clinics, and purchasers should build systems and develop 
formalized agreements or contractual requirements with all testing 
providers to ensure a rapid, welcoming handoff from a testing provider 
to the appropriate clinical staff. 
• Expand low cost evidence-informed approaches 
to promote retention in care. 
Although there is a paucity of proven approaches to improve retention 
in care, those that exist should be rapidly implemented and scaled 
up. A study jointly funded by CDC and HRSA demonstrated that a 
low cost, clinic-wide intervention including posters, brochures, and 
brief messages about coming to visits produced a modest increase 
in retention in care.34 Similarly, a second approach evaluated in the 
study showed that a brief educational session about the importance of 
continuous HIV care followed by personal reminder calls seven and two 
days before scheduled appointments, and within 48 hours of missed 
appointments, led to improved retention in care, at modest cost.35,36 
Notably, the same person who developed a relationship with the study 
participant made the calls. With modest resources, these intervention 
approaches have the potential for considerable impact if there is 
widespread uptake at high volume HIV clinics. 
• Establish programs to actively re-engage people in 
care who have experienced treatment interruptions. 
Because perfect retention over one’s lifetime is a virtually impossible, 
perhaps the most urgent action that health plans and purchasers can 
undertake is to build programs and systems to identify persons at 
risk for extended or terminal gaps in care, and then work to promote 
re-engagement before negative consequences are realized.37 One 
of the major advantages of coordinating integrated data monitoring 
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members in order to activate UM/CC teams and/or work with contracted 
network providers to facilitate care engagement and retention. 
• Clarify responsibilities and strengthen coordination 
among federal agencies. 
No single agency is responsible for HIV testing, public health 
functions such as partner notification and contact tracing, supportive 
services, and medical care. The CDC, HRSA, SAMHSA, and other 
federal agencies are strongly encouraged to commit to promulgating 
coordinated cross-agency guidance on issues related to the HIV care 
continuum and providing clear direction to grantees for resolving 
questions in order to avoid duplication and ensure consistency across 
federal programs. These agencies already have taken important steps 
in this direction, including working with states and local jurisdictions to 
streamline resource planning for federal prevention and care services. 
The status quo, however, in which each federal program issues its own 
guidance, continues to produce confusion in the field and is in need of 
further coordination. Health plans and health care purchasers should 
urge federal agencies to review current guidance related to testing, 
linkage, retention, and adherence to care in order to identify conflicts 
and propose remedies to align guidance across programs or, where 
necessary, to explicitly note divergence in policies across programs.  
For future regulation and policy guidance, there should be a commitment 
that all policy guidance would be reviewed by all relevant agencies, 
with a designated entity within HHS (such as OHAIDP) responsible for 
mediating policy disagreements. 
• Further integrate grantee funding and oversight 
between CDC and HRSA. 
HRSA’s Ryan White Services Report that provides client-level data is 
an important tool for informing program planning and is an important 
complement to the CDC’s Data to Care program and the Medical 
Monitoring Project (MMP).43 While both agencies have greatly expanded 
their collaboration in recent years, substantial new efforts are needed 
to ensure that HIV care and HIV prevention activities are not housed 
in entirely separate silos. This should include detailing key staff from 
one agency to the other, aligning funding announcements, and, 
when possible, issuing blended funding program announcements. 
Furthermore, the expansion of Data to Care and the integration with 
client-level data requires building data management capacity in 
health departments that does not currently exist in most jurisdictions. 
Therefore, joint funding between various parts of the Ryan White HIV/
AIDS Program with an expanded Data to Care program that clearly 
permits health departments to add data management staff could be 
an important way to spur critical progress and reduce local barriers 
to sharing program data between public health authorities focused on 
prevention and those focused on care. Health plans and health care 
Health plans need to become more active in helping individuals with 
HIV to navigate their insurance benefits, access care appropriately, 
and minimize personal out-of-pocket costs. When appropriate, health 
plans also should help members to avail themselves of public and 
private programs that provide supplemental financial assistance (such 
as pharmacy assistance programs, Ryan White AIDS Drug Assistance 
Programs [ADAPs], and other community resources). 
III.  CHANGING POLICY  
(through collaboration  
with federal, state, and  
local policy makers) 
Health plans should seek opportunities to engage with health 
departments, purchasers, and providers to advance an agenda for 
change that creates systems to ensure that standard practices lead 
to optimal care. Whereas the National HIV/AIDS Strategy and other 
policy documents provide a clear vision of what the nation needs to do 
to end the HIV epidemic, translating this vision into actionable steps 
within health plans, provider offices, clinics, and communities is often 
neglected. Many health plans, health care purchasers, and providers 
may perceive their role as caring for individuals and not worrying about 
population-level impact. Nonetheless, there are rich opportunities 
to enact policies that both work toward common national goals and 
facilitate the delivery of high quality care, while also reducing costs. 
ACTION STEPS TO PROMOTE POLICY  
CHANGE TO SUPPORT IMPROVED  
ENGAGEMENT IN HIV CARE 
• Establish “Data to Care” programs in all state 
health departments. 
The CDC has launched a “Data to Care” campaign, providing technical 
assistance for the implementation of health department, clinical, or 
combination models that use surveillance data to facilitate linkage, 
retention, and re-engagement in HIV medical care. New efforts are 
needed to expand on this effort so that all health departments have the 
staffing, capacity, and funding to implement such programs. The CDC 
should be applauded for this initiative, and now is the time to re-allocate 
significant resources to expanding it. Health plans benefit greatly when 
health departments are able to integrate community-wide monitoring 
with client-level data from individual clinics or health plans. Therefore, 
health plans should advocate for access to surveillance data on their 
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purchasers should engage with policy makers around these issues and 
urge their adoption in a manner that facilitates engagement by health 
plans in new data collaborations. 
• Establish standards for Medicare, Medicaid, and 
marketplaces to monitor core HIV indicators, build 
systems to support engagement in HIV care, and 
require fidelity to HHS ART guidelines. 
Medicare and Medicaid are the dominant purchasers of HIV care in 
the U.S., representing more than half of the federal investment in 
domestic HIV spending. To date, while federal policy has encouraged 
these programs to provide quality HIV care, it has failed to use its 
market power to demand that these programs adhere to federal 
evidence-based standards. Federally administered marketplaces 
also have an opportunity to ensure that HIV clinical practices adhere 
to the latest standards. CMS, which oversees Medicaid, Medicare, 
and health care marketplaces, should issue enforceable guidance 
to require all three to collect the same data and actively monitor 
HIV viral suppression and other HHS core HIV indicators. Moreover, 
given that federal ART guidelines are the gold standard for evidence-
based clinical HIV practice guidelines, CMS should establish legally 
enforceable policies across Medicare, Medicaid, and federally 
facilitated marketplaces to ensure that formulary policies are non-
discriminatory and provide appropriate access to ART consistent 
with the latest federal guidelines. Health plans and purchasers 
should support standardization across these programs to ensure that 
individual health plans are not at a competitive disadvantage when 
they meet the current standard of HIV care. 
• Establish state and local data and continuous quality 
improvement collaboratives. 
Given that state and local capacity to manage and use data varies 
dramatically, and health plans and providers may be unclear as 
to how they can contribute to population health initiatives, health 
departments should establish data collaboratives that bring together 
the health department, Medicaid, the marketplace, health plans, 
providers, and community stakeholders to develop a strategic 
plan for sharing data to improve engagement in HIV care. Such 
collaboratives could lead to the development of a clear state or local 
agenda and goals for data sharing, building community support 
for such efforts, examining barriers to sharing and using data, 
and identifying stepwise priorities for action, which can then be 
monitored via continuous quality improvement initiatives. Health 
care purchasers should fund these types of collaboratives at the 
local and state levels, and health plans should proactively engage  
in the establishment of these efforts. 
CONCLUSION 
The U.S. can move forward and better support people with HIV to 
be diagnosed and engaged in continuous medical care. There are 
reasonable and strategic steps that health plans and various health 
care purchasers can take today that will help improve clinical outcomes, 
reduce wasteful spending, and reduce the scope and impact of the  
HIV epidemic in the U.S. 
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